Search research articles
Contact Us
Filters
Showing results (51-60 of 482) with videos related to
Page
of 49
Sort By:
Expert Review of Hematology
|
June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review
Fabio Efficace, Laura Cannella, Massimo Breccia, et al.
Blood Reviews
|
April 9, 2021
AML and the art of remission maintenance
Marcos de Lima, Gail J Roboz, Uwe Platzbecker, et al.
American Journal of Rhinology
|
September 8, 2006
Severe chemotherapy-induced parosmia
Antje Müller, Basile N Landis, Uwe Platzbecker, et al.
Leukemia Research
|
November 25, 2016
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
Antonio Almeida, Pierre Fenaux, Alan F List, et al.
Annals of Hematology
|
December 3, 2019
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Annals of Hematology
|
October 26, 2019
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Cancers
|
October 28, 2023
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
Paula Reichelt, Stephan Bernhart, Franziska Wilke, et al.
Transfusion
|
January 14, 2005
Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells
Uwe Platzbecker, Martin Bornhäuser, Kristin Zimmer, et al.
Journal of Behavioral Medicine
|
February 9, 2025
The impact of experiential avoidance on anxiety and depressive disorders in hematological cancer patients
Gregor Weißflog, Jochen Ernst, Peter Esser, et al.
Leukemia Research
|
May 18, 2010
Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS
Jana Reins, Maximilian Mossner, Martin Neumann, et al.
Page
of 49
Search research articles
Search
Showing results (51-60 of 482) with videos related to
Sort By:
Page
of 49
Expert Review of Hematology
|
June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review
Fabio Efficace, Laura Cannella, Massimo Breccia, et al.
Blood Reviews
|
April 9, 2021
AML and the art of remission maintenance
Marcos de Lima, Gail J Roboz, Uwe Platzbecker, et al.
American Journal of Rhinology
|
September 8, 2006
Severe chemotherapy-induced parosmia
Antje Müller, Basile N Landis, Uwe Platzbecker, et al.
Leukemia Research
|
November 25, 2016
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
Antonio Almeida, Pierre Fenaux, Alan F List, et al.
Annals of Hematology
|
December 3, 2019
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Annals of Hematology
|
October 26, 2019
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
Sophie Park, Charikleia Kelaidi, Mathieu Meunier, et al.
Cancers
|
October 28, 2023
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
Paula Reichelt, Stephan Bernhart, Franziska Wilke, et al.
Transfusion
|
January 14, 2005
Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells
Uwe Platzbecker, Martin Bornhäuser, Kristin Zimmer, et al.
Journal of Behavioral Medicine
|
February 9, 2025
The impact of experiential avoidance on anxiety and depressive disorders in hematological cancer patients
Gregor Weißflog, Jochen Ernst, Peter Esser, et al.
Leukemia Research
|
May 18, 2010
Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS
Jana Reins, Maximilian Mossner, Martin Neumann, et al.
Page
of 49